- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01725932
Randomized Controlled Trial of Cognitive Therapy Based Self Help Manual for Depression (CaCBT_SH)
June 16, 2013 updated by: Pakistan Association of Cognitive Therapists
A Multicentre Randomised Controlled Trial of Culturally Adapted CBT Based Self Help Manual for Depression in Pakistan
While CBT (Cognitive Behaviour Therapy)has been found to be effective in treating depression in West, only limited amount of research has been conducted to find assess its effectiveness in low and middle income countries.
We have developed culturally sensitive CBT during the last few years in Pakistan.
Pakistan has high rates of depression.
And there is currently a need to develop and test evidence based treatments which are culturally sensitive and cost effective.
IN this project we will be assessing the effectiveness of a culturally sensitive CBT based self help intervention for depression in Pakistan against care as usual, using a randomized controlled design.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
192
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All those who fulfil the diagnosis of Depressive episode (F32) or Recurrent depressive disorder (F33 except 33.4 ) using ICD10 RDC (International Classification of Diseases, Research Diagnostic Criteria), scored 8 or more on HADS (Hospital Anxiety and Depression Scale) Depression Sub-scale, are between the ages of 18-60 and either patient or the carer has at least 5 years of education.
Exclusion Criteria:
- The exclusion criteria include; excessive use of alcohol or drugs (using ICD 10 RDC for alcohol or drug abuse or dependence) significant cognitive impairment (for example learning disability or dementia) and active psychosis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Culturally adapted CBT based Self Help
Culturally sensitive cbt based self help intervention, which consists of 6 regular chapters and 2 additional chapters.
The self help intervention involves family to improve compliance with the intervention
|
Intervention was based on our initial work using mixed methods, using mixed methods,in Pakistan.
It focused on psycho-education, symptoms management, changing negative thinking, behavioral activation, problem solving, improving relationships and communication skills.
One person from the family was involved in all cases.
The intervention consists of 7 chapters.
Manual can be used by the patient's or carers with at least 5 years of education.
A member of the research team called them once every week to remind them of the next chapter and also to discuss any issues o problems that emerged during the previous week.
This manual can be downloaded from PACT website (http://www.pactorganization.com/)
|
No Intervention: Care As Usual
Control Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Anxiety and depression Rating Scale- Depression subscale
Time Frame: Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Measurement of depression
|
Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Anxiety and Depression Scale, Anxiety subscale
Time Frame: Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Measurement of anxiety
|
Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Bradford Somatic Inventory
Time Frame: Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Measurement of somatic symptoms
|
Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Brief disability questionnaire
Time Frame: Participants will be assessed at baseline and then end of therapy at 12 weeks
|
To measure disability associated with depression
|
Participants will be assessed at baseline and then end of therapy at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Mehwish Khalid, MSc, PACT
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
October 31, 2012
First Submitted That Met QC Criteria
November 8, 2012
First Posted (Estimate)
November 14, 2012
Study Record Updates
Last Update Posted (Estimate)
June 18, 2013
Last Update Submitted That Met QC Criteria
June 16, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PACT_SHCBTD_2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
Clinical Trials on Culturally adapted CBT based Self Help
-
Centre for Addiction and Mental HealthRecruitingDepression | AnxietyCanada
-
University of EdinburghUnknownDepression | Anxiety | Type 2 DiabetesUnited Kingdom
-
University of CologneEli Lilly and CompanyCompletedAttention-Deficit/Hyperactivity DisorderGermany
-
University of CologneEli Lilly and CompanyCompletedAttention-Deficit/Hyperactivity DisorderGermany
-
University of BernUniversitätsklinikum Hamburg-EppendorfCompletedSchizophrenia | Hallucinations | Persecutory DelusionGermany, Switzerland
-
Koç UniversityRecruitingDepressive Symptoms | Psychological Distress | Well-Being, PsychologicalTurkey
-
Chinese University of Hong KongNot yet recruitingDepression | Insomnia
-
Pakistan Association of Cognitive TherapistsCompleted
-
Uppsala UniversityCompletedDepression | Cancer | AnxietySweden